Boston Scientific Corporation vs Johnson & Johnson — Stock Comparison

BSX
Boston Scientific Corporation
$56.50
▼ 1.93%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Boston Scientific Corporation
BSX8.7/10vs 7.1/10

Q·Score Breakdown

8.7
Very Bullish
Overall
7.1
Bullish
7.7
Quality
9.3
9.1
Health
6.5
8.8
Growth
5.1
9.1
Valuation
7.3
9
Sentiment
6.5
BSX

Clean balance sheet with low leverage (0.4× debt-to-equity).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

BUY
Target $85.19 (+50.8%)
32 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

BSX
JNJ
23.6×
Trailing P/E
26.3×
15.0×
Forward P/E
17.9×
17.3%
Profit Margin
21.8%
68.9%
Gross Margin
68.0%
14.7%
ROE
26.4%
11.6%
Revenue Growth
9.9%
100.0%
Earnings Growth
-52.9%
0.78
Beta
0.33
Price / Book
$84.0B
Market Cap
$546.9B
$56 – $110
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →